Total Payments
$7,139
2023 Payments
$1,235
Companies
39
Transactions
643
Medicare Patients
10,085
Medicare Billing
$297,335
Payment Breakdown by Category
Food & Beverage$6,840 (95.8%)
Education$298.73 (4.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,840 | 630 | 95.8% |
| Education | $298.73 | 13 | 4.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,034 | 117 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $912.65 | 51 | $0 (2023) |
| Merck Sharp & Dohme LLC | $849.80 | 113 | $0 (2023) |
| GlaxoSmithKline, LLC. | $603.74 | 62 | $0 (2023) |
| AbbVie Inc. | $559.88 | 57 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $353.21 | 33 | $0 (2022) |
| Astellas Pharma US Inc | $339.90 | 17 | $0 (2021) |
| Amarin Pharma Inc. | $253.56 | 29 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $236.94 | 23 | $0 (2023) |
| Lilly USA, LLC | $202.68 | 14 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $1,235 | 76 | AbbVie Inc. ($178.23) |
| 2022 | $1,178 | 93 | AstraZeneca Pharmaceuticals LP ($191.35) |
| 2021 | $763.93 | 65 | AbbVie Inc. ($170.57) |
| 2020 | $187.44 | 14 | AstraZeneca Pharmaceuticals LP ($35.72) |
| 2019 | $1,038 | 108 | Novo Nordisk Inc ($172.35) |
| 2018 | $1,208 | 121 | Novo Nordisk Inc ($265.37) |
| 2017 | $1,528 | 166 | Novo Nordisk Inc ($349.25) |
All Payment Transactions
643 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/07/2023 | AbbVie Inc. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: NEUROSCIENCE | ||||||
| 09/07/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Hematology | ||||||
| 09/05/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $21.25 | General |
| Category: THERAPY FOR CSID | ||||||
| 08/31/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: RESPIRATORY | ||||||
| 08/29/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Diabetes Care | ||||||
| 08/29/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Diabetes Care | ||||||
| 08/29/2023 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: HEMATOLOGY | ||||||
| 08/29/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/21/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $7.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/15/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Cardio-renal | ||||||
| 08/09/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: PSYCHIATRY | ||||||
| 08/03/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/27/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Neuroscience | ||||||
| 07/27/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Diabetes | ||||||
| 07/24/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: NEUROSCIENCE | ||||||
| 07/20/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $21.83 | General |
| Category: THERAPY FOR CSID | ||||||
| 07/18/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Oncology | ||||||
| 07/13/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Respiratory | ||||||
| 07/13/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Respiratory | ||||||
| 06/28/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Respiratory | ||||||
| 06/23/2023 | Merck Sharp & Dohme LLC | ZINPLAVA (Biological) | Education | In-kind items and services | $10.85 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/22/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Diabetes | ||||||
| 06/20/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Cardio-renal | ||||||
| 06/16/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 1,803 | 2,117 | $101,654 | $45,730 |
| 2022 | 41 | 2,725 | 3,433 | $174,975 | $82,469 |
| 2021 | 39 | 2,919 | 3,676 | $185,613 | $90,721 |
| 2020 | 48 | 2,638 | 3,149 | $165,720 | $78,416 |
Total Patients
10,085
Total Services
12,375
Medicare Billing
$297,335
Procedure Codes
157
All Medicare Procedures & Services
157 procedure records from CMS Medicare Utilization — Page 2 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 13 | 13 | $286.00 | $114.92 | 40.2% |
| 84478 | Triglycerides level | Office | 2023 | 20 | 20 | $260.00 | $112.60 | 43.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $900.00 | $87.20 | 9.7% |
| 82550 | Creatine kinase (cardiac enzyme) level, total | Office | 2023 | 11 | 13 | $195.00 | $82.94 | 42.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 193 | 193 | $33,775 | $24,638 | 72.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 172 | 207 | $34,399 | $15,419 | 44.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 131 | 169 | $19,870 | $9,723 | 48.9% |
| 82306 | Vitamin d-3 level | Office | 2022 | 125 | 137 | $9,590 | $3,971 | 41.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 50 | 50 | $5,194 | $3,420 | 65.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 196 | 281 | $7,025 | $2,913 | 41.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 169 | 190 | $6,840 | $2,507 | 36.7% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 128 | 201 | $4,623 | $1,928 | 41.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 187 | 249 | $3,984 | $1,898 | 47.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 87 | 110 | $3,850 | $1,808 | 47.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2022 | 87 | 104 | $7,280 | $1,536 | 21.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 253 | 501 | $6,071 | $1,484 | 24.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 50 | 50 | $1,600 | $1,399 | 87.4% |
| 83721 | Ldl cholesterol level | Office | 2022 | 109 | 118 | $4,012 | $1,207 | 30.1% |
| 82746 | Folic acid level, serum | Office | 2022 | 63 | 68 | $4,556 | $973.85 | 21.4% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2022 | 73 | 90 | $1,980 | $750.72 | 37.9% |
| 82728 | Ferritin (blood protein) level | Office | 2022 | 47 | 56 | $1,624 | $742.68 | 45.7% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2022 | 17 | 17 | $2,125 | $691.82 | 32.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 18 | 18 | $810.00 | $506.78 | 62.6% |
| 82465 | Cholesterol level | Office | 2022 | 108 | 117 | $1,170 | $495.75 | 42.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 11 | 13 | $1,573 | $492.62 | 31.3% |
About Dr. Lora Brown, MD
Dr. Lora Brown, MD is a Internal Medicine healthcare provider based in Gahanna, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1770634701.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lora Brown, MD has received a total of $7,139 in payments from pharmaceutical and medical device companies, with $1,235 received in 2023. These payments were reported across 643 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($6,840).
As a Medicare-enrolled provider, Brown has provided services to 10,085 Medicare beneficiaries, totaling 12,375 services with total Medicare billing of $297,335. Data is available for 4 years (2020–2023), covering 157 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Gahanna, OH
- Active Since 01/16/2007
- Last Updated 05/01/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1770634701
Products in Payments
- FARXIGA (Drug) $747.11
- JANUVIA (Drug) $418.75
- Victoza (Drug) $274.02
- UBRELVY (Drug) $257.77
- Vascepa (Drug) $253.56
- Ozempic (Drug) $216.38
- TRELEGY ELLIPTA (Drug) $209.65
- Saxenda (Drug) $198.68
- NURTEC ODT (Drug) $169.50
- JARDIANCE (Drug) $156.47
- BREO (Drug) $154.56
- FREESTYLE LIBRE 2 (Device) $151.68
- SOLIQUA (Drug) $131.12
- BREZTRI (Drug) $126.91
- Tresiba (Drug) $126.68
- Cologuard Collection Kit (Device) $123.22
- XARELTO (Drug) $121.45
- ANORO (Drug) $119.64
- Trintellix (Drug) $117.21
- Rybelsus (Drug) $111.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Gahanna
Muhammad Afzal, M.d, M.D
Internal Medicine — Payments: $36,850
Internal Medicine $36,850
David Nicholson, D.o, D.O
Internal Medicine — Payments: $17,946
Internal Medicine $17,946
Albert Salomon, D.o, D.O
Internal Medicine — Payments: $9,573
Internal Medicine $9,573
Dr. Lisa Braverman, Md, MD
Internal Medicine — Payments: $3,354
Internal Medicine $3,354
Dr. Jason Craft, Md, MD
Internal Medicine — Payments: $458.51
Internal Medicine $458.51
Dr. Samia Hina Awan, Mbbs, MBBS
Internal Medicine — Payments: $225.31
Internal Medicine $225.31